Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0331 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2008-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_686d41adab18f72546d470c8ecbd00dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bc66fec4880493d43d73e88d4974da1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c8df486615de39d3b4225fd5fe3aade http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_480baa935eae6b6617690edf992e5332 |
publicationDate |
2014-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2008321835-B2 |
titleOfInvention |
Monoclonal antibody capable of binding to anexelekto, and use thereof |
abstract |
An anti-AXL antibody having a specific function can be successfully obtained. It is found that the antibody has an anti-angiogenic activity and an anti-cancer activity. The anti-AXL antibody is useful as an anti-angiogenic agent or an agent for inducing or inhibiting a phosphorylation activity. |
priorityDate |
2007-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |